Average Co-Inventor Count = 5.97
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (11 from 1,976 patents)
2. Genesoft Pharmaceuticals, Inc. (4 from 9 patents)
3. Epix Pharmaceuticals, Inc. (2 from 14 patents)
4. Oscient Pharmaceuticals Corporation (1 from 18 patents)
5. Genesoft, Inc. (1 from 3 patents)
18 patents:
1. 8349868 - Azaquinolones that inhibit prolyl hydroxylase
2. 8097620 - Diazaquinolones that inhibit prolyl hydroxylase activity
3. 8080542 - S1P receptor modulating compounds and use thereof
4. 8048894 - Quinolones and azaquinolones that inhibit prolyl hydroxylase
5. 8030346 - Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity
6. 8017626 - Quinolone based compounds exhibiting, prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
7. 8012968 - Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
8. 7928139 - Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
9. 7919519 - S1P receptor modulating compounds and use thereof
10. 7728130 - Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity
11. 7642245 - Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
12. 7635715 - Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
13. 7569726 - Indanone derivatives that inhibit prolyl hydroxylase
14. 7498349 - Biaryl compounds having anti-infective activity
15. 7498405 - Halogen-substituted thienyl compounds